105 related articles for article (PubMed ID: 15838300)
1. Down-regulation of ETA receptors in ETB receptor-deficient mice.
Davenport AP; Kuc RE
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S276-8. PubMed ID: 15838300
[TBL] [Abstract][Full Text] [Related]
2. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.
Davenport AP; O'Reilly G; Kuc RE
Br J Pharmacol; 1995 Mar; 114(6):1110-6. PubMed ID: 7620699
[TBL] [Abstract][Full Text] [Related]
3. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
Davenport AP; Kuc RE; Ashby MJ; Patt WC; Doherty AM
Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
Peter MG; Davenport AP
Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptors in human coronary artery and aorta.
Bacon CR; Davenport AP
Br J Pharmacol; 1996 Mar; 117(5):986-92. PubMed ID: 8851522
[TBL] [Abstract][Full Text] [Related]
6. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.
Davenport AP; O'Reilly G; Molenaar P; Maguire JJ; Kuc RE; Sharkey A; Bacon CR; Ferro A
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S22-5. PubMed ID: 7509950
[TBL] [Abstract][Full Text] [Related]
7. Characterization of peptide and nonpeptide antagonists in human kidney.
Kuc RE; Karet FE; Davenport AP
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S373-5. PubMed ID: 8587419
[TBL] [Abstract][Full Text] [Related]
8. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242.
Bacon CR; Morrison JJ; O'Reilly G; Cameron IT; Davenport AP
J Endocrinol; 1995 Jan; 144(1):127-34. PubMed ID: 7891013
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the binding of endothelin ETB selective ligands in human and rat heart.
Russell FD; Davenport AP
Br J Pharmacol; 1996 Oct; 119(4):631-6. PubMed ID: 8904635
[TBL] [Abstract][Full Text] [Related]
10. [125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature.
Davenport AP; Kuc RE; Hoskins SL; Karet FE; Fitzgerald F
Br J Pharmacol; 1994 Dec; 113(4):1303-10. PubMed ID: 7534185
[TBL] [Abstract][Full Text] [Related]
11. Comparison of endothelin-A and endothelin-B receptor distribution visualized by radioligand binding versus immunocytochemical localization using subtype selective antisera.
Kuc R; Davenport AP
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S224-6. PubMed ID: 15838285
[TBL] [Abstract][Full Text] [Related]
12. Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas.
Harland SP; Kuc RE; Pickard JD; Davenport AP
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S408-11. PubMed ID: 8587429
[TBL] [Abstract][Full Text] [Related]
13. Quantification of endothelin receptor subtypes in peripheral tissues reveals downregulation of ET(A) receptors in ET(B)-deficient mice.
Kuc RE; Maguire JJ; Davenport AP
Exp Biol Med (Maywood); 2006 Jun; 231(6):741-5. PubMed ID: 16740991
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.
Nambi P; Pullen M; Kincaid J; Nuthulaganti P; Aiyar N; Brooks DP; Gellai M; Kumar C
Mol Pharmacol; 1997 Oct; 52(4):582-9. PubMed ID: 9380020
[TBL] [Abstract][Full Text] [Related]
15. Distinct Alteration in Brain Endothelin A and B Receptor Characteristics Following Focal Cerebral Ischemia in Rats.
Bhalla S; Leonard MG; Briyal S; Gulati A
Drug Res (Stuttg); 2016 Apr; 66(4):189-95. PubMed ID: 26398673
[TBL] [Abstract][Full Text] [Related]
16. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.
Karet FE; Kuc RE; Davenport AP
Kidney Int; 1993 Jul; 44(1):36-42. PubMed ID: 8355464
[TBL] [Abstract][Full Text] [Related]
17. Endothelin receptor pharmacology and function in the mouse: comparison with rat and man.
Wiley KE; Davenport AP
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S4-6. PubMed ID: 15838332
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020.
Jarvis MF; Assal AA; Gessner G
Brain Res; 1994 Nov; 665(1):33-8. PubMed ID: 7882015
[TBL] [Abstract][Full Text] [Related]
19. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
Widdowson PS; Kirk CN
Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551
[TBL] [Abstract][Full Text] [Related]
20. Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.
Rossi G; Albertin G; Belloni A; Zanin L; Biasolo MA; Prayer-Galetti T; Bader M; Nussdorfer GG; Palù G; Pessina AC
J Clin Invest; 1994 Sep; 94(3):1226-34. PubMed ID: 8083364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
